Key Benefits
-
Dual-Vial Flexibility: Choose the 100u vial for focused treatments and patient customization, or the 200u vial for practice efficiency and reduced waste in high-volume settings.
-
High Purity & Precision: The 900kDa formulation and purification process are associated with a targeted, localized effect, allowing for precise muscle modulation and predictable, natural-looking outcomes.
-
FDA-Approved Consistency: As an FDA-approved product for glabellar lines, Nabota offers the reliability and documented safety profile that practitioners and patients trust.
-
Strong Value Proposition: Provides a competitive balance of performance, purity, and cost, making it an excellent option for both expanding a practice and maintaining treatment quality.
Target Areas for Treatment
Important Tips for Medical Practitioners
-
Follow Nabota-Specific Dosing: Nabota units are not directly interchangeable with other neuromodulators. While its unit potency is often considered comparable to Botox Cosmetic for glabellar lines, always initiate treatment using dosing guidelines specific to Nabota and adjust based on individual patient response and muscle mass.
-
Optimize Reconstitution for Precision: For the 100u vial, common dilutions are 1.0 mL, 2.0 mL, or 2.5 mL of preservative-free saline. For the 200u vial, proportional volumes (e.g., 2.0 mL, 4.0 mL, or 5.0 mL) achieve the same concentrations. A moderate dilution (e.g., 2.5 mL/100u) often provides an excellent balance of precision and spread.
-
Leverage its Localized Profile: Nabota is characterized by relatively focused diffusion. This allows for precise placement, which is advantageous for sculpting (e.g., brow lift) but may require more injection points for broader areas like the forehead to ensure even smoothing.
-
Storage & Handling Protocol: Store unopened vials refrigerated (2°C to 8°C). Post-reconstitution, use within 24 hours when stored under refrigeration. The 200u vial requires careful planning; schedule treatments to use the entire vial promptly after reconstitution to maintain potency and sterility.
-
Patient Selection & Consultation: As with all toxins, a thorough dynamic facial analysis is crucial. Discuss Nabota specifically with patients, highlighting its FDA approval and purity. Manage expectations regarding onset (typically 2-5 days) and duration (3-4 months).
Disclaimer: This information is for professional educational use only. The safe and effective administration of Nabota requires appropriate medical training, licensure, and expertise in facial anatomy. Alura Medical Supply verifies active medical licenses for all orders.